Phase I Trial of High Dose Lenalidomide in Patients With Refractory/Relapsed Acute Leukemia as a Bridge to Bone Marrow Transplant
Phase of Trial: Phase I
Latest Information Update: 11 Jan 2018
At a glance
- Drugs Lenalidomide (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 05 Jan 2018 Status changed from suspended to discontinued.
- 03 Nov 2017 Planned End Date changed from 1 Aug 2018 to 1 Dec 2017.
- 03 Nov 2017 Status changed from active, no longer recruiting to suspended.